-
Je něco špatně v tomto záznamu ?
Effects of branched-chain amino acids on muscles under hyperammonemic conditions
M. Holeček, M. Vodeničarovová,
Jazyk angličtina Země Španělsko
Typ dokumentu srovnávací studie, časopisecké články
- MeSH
- amoniak otrava MeSH
- citrátový cyklus účinky léků MeSH
- glutamin agonisté metabolismus MeSH
- hyperamonemie enzymologie metabolismus patofyziologie MeSH
- jaterní cirhóza etiologie metabolismus MeSH
- kyseliny ketoglutarové metabolismus MeSH
- methylhistidiny metabolismus MeSH
- orgánová specificita MeSH
- osmolární koncentrace MeSH
- oxidace-redukce MeSH
- potkani Wistar MeSH
- proteolýza účinky léků MeSH
- proteosyntéza účinky léků MeSH
- radioizotopy uhlíku MeSH
- svalová vlákna typu I účinky léků enzymologie metabolismus MeSH
- svalová vlákna typu II účinky léků enzymologie metabolismus MeSH
- svalové proteiny genetika metabolismus MeSH
- techniky in vitro MeSH
- větvené aminokyseliny metabolismus MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
The aim was to determine the effects of enhanced availability of branched-chain amino acids (BCAAs; leucine, isoleucine, and valine) on ammonia detoxification to glutamine (GLN) and protein metabolism in two types of skeletal muscle under hyperammonemic conditions. Isolated soleus (SOL, slow-twitch) and extensor digitorum longus (EDL, fast-twitch) muscles from the left leg of white rats were incubated in a medium with 1 mM ammonia (NH3 group), BCAAs at four times the concentration of the controls (BCAA group) or high levels of both ammonia and BCAA (NH3 + BCAA group). The muscles from the right leg were incubated in basal medium and served as paired controls. L-[1-14C]leucine was used to estimate protein synthesis and leucine oxidation, and 3-methylhistidine release was used to evaluate myofibrillar protein breakdown. We observed decreased protein synthesis and glutamate and α-ketoglutarate (α-KG) levels and increased leucine oxidation, GLN levels, and GLN release into medium in muscles in NH3 group. Increased leucine oxidation, release of branched-chain keto acids and GLN into incubation medium, and protein synthesis in EDL were observed in muscles in the BCAA group. The addition of BCAAs to medium eliminated the adverse effects of ammonia on protein synthesis and adjusted the decrease in α-KG found in the NH3 group. We conclude that (i) high levels of ammonia impair protein synthesis, activate BCAA catabolism, enhance GLN synthesis, and decrease glutamate and α-KG levels and (ii) increased BCAA availability enhances GLN release from muscles and attenuates the adverse effects of ammonia on protein synthesis and decrease in α-KG.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012515
- 003
- CZ-PrNML
- 005
- 20210209101251.0
- 007
- ta
- 008
- 190405s2018 sp f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s13105-018-0646-9 $2 doi
- 035 __
- $a (PubMed)30058052
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sp
- 100 1_
- $a Holeček, Milan $u Department of Physiology, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, 500 03, Hradec Kralove, Czech Republic. holecek@lfhk.cuni.cz.
- 245 10
- $a Effects of branched-chain amino acids on muscles under hyperammonemic conditions / $c M. Holeček, M. Vodeničarovová,
- 520 9_
- $a The aim was to determine the effects of enhanced availability of branched-chain amino acids (BCAAs; leucine, isoleucine, and valine) on ammonia detoxification to glutamine (GLN) and protein metabolism in two types of skeletal muscle under hyperammonemic conditions. Isolated soleus (SOL, slow-twitch) and extensor digitorum longus (EDL, fast-twitch) muscles from the left leg of white rats were incubated in a medium with 1 mM ammonia (NH3 group), BCAAs at four times the concentration of the controls (BCAA group) or high levels of both ammonia and BCAA (NH3 + BCAA group). The muscles from the right leg were incubated in basal medium and served as paired controls. L-[1-14C]leucine was used to estimate protein synthesis and leucine oxidation, and 3-methylhistidine release was used to evaluate myofibrillar protein breakdown. We observed decreased protein synthesis and glutamate and α-ketoglutarate (α-KG) levels and increased leucine oxidation, GLN levels, and GLN release into medium in muscles in NH3 group. Increased leucine oxidation, release of branched-chain keto acids and GLN into incubation medium, and protein synthesis in EDL were observed in muscles in the BCAA group. The addition of BCAAs to medium eliminated the adverse effects of ammonia on protein synthesis and adjusted the decrease in α-KG found in the NH3 group. We conclude that (i) high levels of ammonia impair protein synthesis, activate BCAA catabolism, enhance GLN synthesis, and decrease glutamate and α-KG levels and (ii) increased BCAA availability enhances GLN release from muscles and attenuates the adverse effects of ammonia on protein synthesis and decrease in α-KG.
- 650 _2
- $a větvené aminokyseliny $x metabolismus $7 D000597
- 650 _2
- $a amoniak $x otrava $7 D000641
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a radioizotopy uhlíku $7 D002250
- 650 _2
- $a citrátový cyklus $x účinky léků $7 D002952
- 650 _2
- $a glutamin $x agonisté $x metabolismus $7 D005973
- 650 _2
- $a hyperamonemie $x enzymologie $x metabolismus $x patofyziologie $7 D022124
- 650 _2
- $a techniky in vitro $7 D066298
- 650 _2
- $a kyseliny ketoglutarové $x metabolismus $7 D007656
- 650 _2
- $a jaterní cirhóza $x etiologie $x metabolismus $7 D008103
- 650 _2
- $a methylhistidiny $x metabolismus $7 D008762
- 650 _2
- $a svalová vlákna typu II $x účinky léků $x enzymologie $x metabolismus $7 D018656
- 650 _2
- $a svalová vlákna typu I $x účinky léků $x enzymologie $x metabolismus $7 D018657
- 650 _2
- $a svalové proteiny $x genetika $x metabolismus $7 D009124
- 650 _2
- $a orgánová specificita $7 D009928
- 650 _2
- $a osmolární koncentrace $7 D009994
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a proteosyntéza $x účinky léků $7 D014176
- 650 _2
- $a proteolýza $x účinky léků $7 D059748
- 650 _2
- $a potkani Wistar $7 D017208
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vodeničarová, Melita $u Department of Physiology, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, 500 03, Hradec Kralove, Czech Republic. $7 xx0129053
- 773 0_
- $w MED00181630 $t Journal of physiology and biochemistry $x 1877-8755 $g Roč. 74, č. 4 (2018), s. 523-530
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30058052 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20210209101206 $b ABA008
- 999 __
- $a ok $b bmc $g 1391825 $s 1050820
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 74 $c 4 $d 523-530 $e 20180730 $i 1877-8755 $m Journal of physiology and biochemistry $n J Physiol Biochem $x MED00181630
- LZP __
- $a Pubmed-20190405